Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

European Commission approves PONVORY™ --- A Once Daily Oral Treatment for Adults with Relapsing Forms of Multiple Sclerosis

americanpharmaceuticalreviewMay 25, 2021

Tag: PONVORY , Janssen , RMS , teriflunomide

PharmaSources Customer Service